<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmccomplementalternmed&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Complementary and Alternative Medicine - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmccomplementalternmed/</link>
        <description>The latest research articles published by BMC Complementary and Alternative Medicine</description>
        <dc:date>2010-01-29T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/6" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/5" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/4" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/3" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/2" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/10/1" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/53" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/52" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/51" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/50" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/6">
        <title>Antibacterial activity of Artemisia nilagirica leaf extracts against clinical and phytopathogenic bacteria.</title>
        <description>Background:
The six organic solvent extracts of Artemisia nilagirica were screened for the potential antimicrobial activity against phytopathogens and clinically important standard reference bacterial strains.
Methods:
The agar disk diffusion method was used to study the antibacterial activity of A. nilagirica extracts against 15 bacterial strains. The Minimum Inhibitory Concentration (MIC)  of  the  plant  extracts  were  tested  using  two  fold  agar  dilution  method  at concentrations  ranging  from  32  to  512 mug/ml. The phytochemical  screening  of  extracts was carried out for major phytochemical derivatives in A. nilagirica.
Results:
All the extracts showed inhibitory activity for gram-positive and gram-negative bacteria  except  for  Klebsiella  pneumonia,  Enterococcus  faccalis  and  Staphylococcus aureus. The hexane extract was found to be effective against all phytopathogens with low MIC of 32 mug/ml and the methanol extract exhibited a higher  inhibition activity against Escherichia  coli,  Yersinia  enterocolitica,  Salmonella  typhi,  Entrobacter  acrogens, Proteus valgaris, Pseudomonas aeruginosa (32 mug/ml), Basillus subtilis (64 mug/ml) and Shigella flaxneri (128 mug/ml). The phytochemical screening of extracts answered for the major  derivative  of  alkaloids,  amino  acids,  flavonoids,  phenol,  quinines,  tannins  and terpenoids.
Conclusion:
All the extracts showed antibacterial activity against the tested strains. However, methanol and hexane extracts showed high inhibition against clinical and phytopathogens, respectively. The results also indicate the presence of major phytochemical derivatives in the A. nilagirica extracts.  Hence, the isolation and purification of therapeutic potential compounds from A. nilagirica could be used as an effective source against bacterial diseases in human and plants.</description>
        <link>http://www.biomedcentral.com/1472-6882/10/6</link>
                <dc:creator>Abdul Ahameethunisa</dc:creator>
                <dc:creator>Hopper W</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:6</dc:source>
        <dc:date>2010-01-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-6</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2010-01-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/5">
        <title>What rheumatologists in the United States think of complementary and alternative medicine: results of a national survey</title>
        <description>Background:
We aimed to describe prevailing attitudes and practices of rheumatologists in the United States toward complementary and alternative medicine (CAM) treatments. We wanted to determine whether rheumatologists&apos; perceptions of the efficacy of CAM therapies and their willingness to recommend them relate to their demographic characteristics, geographic location, or clinical practices.
Methods:
A National Institutes of Health-sponsored cross sectional survey of internists and rheumatologists was conducted regarding CAM for treatment of chronic back pain or joint pain. In this study we analyzed responses only from rheumatologists. Response items included participant characteristics and experience with 6 common CAM categories, as defined by the National Institutes of Health. Descriptive statistics were used to describe attitudes to CAM overall and to each CAM category. Composite responses were devised for respondents designating 4 or more of the 6 CAM therapies as &quot;very&quot; or &quot;moderately&quot; beneficial or &quot;very likely&quot; or &quot;somewhat likely&quot; to recommend.
Results:
Of 600 rheumatologists who were sent the questionnaire, 345 responded (58%); 80 (23%) were women. Body work had the highest perceived benefit, with 70% of respondents indicating benefit. Acupuncture was perceived as beneficial by 54%. Most were willing to recommend most forms of CAM. Women had significantly higher composite benefit and recommend responses than men. Rheumatologists not born in North America were more likely to perceive benefit of select CAM therapies.
Conclusions:
In this national survey of rheumatologists practicing in the United States, we found widespread favorable opinion toward many, but not all, types of CAM. Further research is required to determine to what extent CAM can or should be integrated into the practice of rheumatology in the United States.</description>
        <link>http://www.biomedcentral.com/1472-6882/10/5</link>
                <dc:creator>Nisha Manek</dc:creator>
                <dc:creator>Cynthia Crowson</dc:creator>
                <dc:creator>Abigale Ottenberg</dc:creator>
                <dc:creator>Farr Curlin</dc:creator>
                <dc:creator>Ted Kaptchuk</dc:creator>
                <dc:creator>Jon Tilburt</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:5</dc:source>
        <dc:date>2010-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-5</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/4">
        <title>The antioxidant and antiproliferative activities of methanolic extracts from Njavara rice bran</title>
        <description>Background:
Free radical-induced oxidative stress is the root cause for many human diseases. Naturally occurring antioxidant supplements from plants are vital to counter the oxidative damage in cells. The main objective of the present study was to characterize the antioxidant  and antiproliferative potential of rice bran extracted from an important Indian rice variety, Njavara and to compare the same with two commercially available basmati rice varieties: Vasumathi, Yamini and a non medicinal variety, Jyothi.
Methods:
Methanolic extracts of rice bran from four varieties; Vasumathi, Yamini, Jyothi and Njavara were used to study their total phenolic and flavonoid contents, in vitro antioxidant activities including total antioxidant activity, scavenging of nitric oxide and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical, reducing power and cytotoxic activity in C6 glioma cells. Correlation coefficient and regression analysis were done by using Sigmastat version 3.1 and Stata statistical package respectively.
Results:
Rice bran methanolic extract from Njavara showed the highest antioxidant and cell cytotoxic properties compared to the other three rice varieties. IC50 values for scavenging DPPH and nitric oxide were in the range of 30.85-87.72 ug/ml and 52.25-107.18 ug/ml respectively. Total antioxidant activity and reducing power were increased with increasing amounts of the extract. Total phenolic and flavonoid contents were in the range of 3.2-12.4 mg gallic acid-equivalent (GAE)/g bran and 1.68-8.5 mg quercetin-equivalent (QEE)/g bran respectively. IC50 values of cytotoxic assay (MTT assay) were 17.53-57.78 ug/ml. Correlation coefficient and regression analysis of phenolic content with DPPH and NO scavenging, MTT (-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay, total antioxidant assay and reducing power showed a highly significant correlation coefficient values (96-99%) and regression values (91-98%).
Conclusion:
The results of the present study show that the crude methanolic extract from Njavara rice bran contains significantly high polyphenolic compounds with superior antioxidant activity as evidenced by scavenging of free radicals including DPPH and NO. Njavara extracts also showed highest reducing power activity, anti-proliferative property in C6 glioma cells. In conclusion, it is conceivable that the Njavara rice variety could be exploited as one of the potential sources for plant - based pharmaceutical products.</description>
        <link>http://www.biomedcentral.com/1472-6882/10/4</link>
                <dc:creator>Akiri Rao</dc:creator>
                <dc:creator>Sareddy Reddy</dc:creator>
                <dc:creator>Phanithi Babu</dc:creator>
                <dc:creator>Attipalli Reddy</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:4</dc:source>
        <dc:date>2010-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-4</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/3">
        <title>Diagnoses and visit length in complementary and mainstream medicine </title>
        <description>Background:
The demand for complementary medicine (CM) is growing worldwide and so is the supply. So far, there is not much insight in the activities in Dutch CM practices nor in how these activities differ from mainstream general practice. Comparisons on diagnoses and visit length can offer an impression of how Dutch CM practices operate.
Methods:
Three groups of regularly trained physicians specialized in CM participated in this study: 16 homeopathic physicians, 13 physician acupuncturists and 11 naturopathy physicians. Every CM physician was asked to include a maximum of 75 new patients within a period of six months. For each patient an inclusion registration form had to be completed and the activities during a maximum of five repeat visits were subsequently registered. Registrations included patient characteristics, diagnoses and visit length. These data could be compared with similar data from general practitioners (GPs) participating in the second Dutch national study in general practice (DNSGP-2). Differences between CM practices and between CM and mainstream GP data were tested using multilevel regression analysis.
Results:
The CM physicians registered activities in a total of 5919 visits in 1839 patients. In all types of CM practices general problems (as coded in the ICPC) were diagnosed more often than in mainstream general practice, especially fatigue, allergic reactions and infections. Psychological problems and problems with the nervous system were also diagnosed more frequently. In addition, each type of CM physician encountered specific health problems: in acupuncture problems with the musculoskeletal system prevailed, in homeopathy skin problems and in naturopathy gastrointestinal problems. Comparisons in visit length revealed that CM physicians spent at least twice as much time with patients compared to mainstream GPs.
Conclusions:
CM physicians differed from mainstream GPs in diagnoses, partly related to general and partly to specific diagnoses. Between CM practices differences were found on specific domains of complaints. Visit length was much longer in CM practices compared to mainstream GP visits, and such ample time may be one of the attractive features of CM for patients.</description>
        <link>http://www.biomedcentral.com/1472-6882/10/3</link>
                <dc:creator>Phil Heiligers</dc:creator>
                <dc:creator>Judith de Groot</dc:creator>
                <dc:creator>Dick Koster</dc:creator>
                <dc:creator>Sandra van Dulmen</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:3</dc:source>
        <dc:date>2010-01-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-3</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/2">
        <title>Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels
</title>
        <description>Background:
Morinda citrifolia (Noni) is an edible plant with wide range of medicinal uses. It occurs exclusively in tropical climate zone from India through Southeast Asia and Australia to Eastern Polynesia and Hawaii. The objective of this study was to explore the possibal mode(s) of action for its antispasmodic, vasodilator and cardio-suppressant effects to rationalize its medicinal use in gut and cardiovascular disorders.
Methods:
Isolated tissue preparations such as, rabbit jejunum, rat and rabbit aorta and guinea pig atria were used to test the antispasmodic and cardiovascular relaxant effects and the possible mode of action(s) of the 70% aqueous-ethanolic extract of Morinda citrifolia roots (Mc.Cr).
Results:
The Mc.Cr produced a concentration-dependent relaxation of spontaneous and high K+ induced contractions in isolated rabbit jejunum preparations. It also caused right ward shift in the concentration response curves of Ca++, similar to that of verapamil. In guinea-pig right atria, Mc.Cr caused inhibition of both atrial force and rate of spontaneous contractions. In rabbit thoracic aortic preparations, Mc.Cr also suppressed contractions induced by phenylephrine (1.0 muM) in normal- Ca++ and Ca++-free kreb solutions and by high K+, similar to that of verapamil. In rat thoracic aortic preparations, Mc.Cr also relaxed the phenylephrine (1.0 muM)-induced contractions. The vasodilatory responses were not altered in the presence of L-NAME (0.1 mM) or atropine (1.0 muM) and removal of endothelium.
Conclusions:
These results suggest that the spasmolytic and vasodilator effects of Mc.Cr root extract are mediated possibly through blockade of voltage-dependent calcium channels and release of intracellular calcium, which may explain the medicinal use of Morinda citrifolia in diarrhea and hypertension. However, more detailed studies are required to assess the safety and efficacy of this plant.</description>
        <link>http://www.biomedcentral.com/1472-6882/10/2</link>
                <dc:creator>Anwarul Hassan Gilani</dc:creator>
                <dc:creator>Saf-ur-Rehman Mandukhail</dc:creator>
                <dc:creator>Javeid Iqbal</dc:creator>
                <dc:creator>Masoom Yasinzai</dc:creator>
                <dc:creator>Nauman Aziz</dc:creator>
                <dc:creator>Aslam Khan</dc:creator>
                <dc:creator>Najeeb-ur -Rehman</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:2</dc:source>
        <dc:date>2010-01-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-2</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-01-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/10/1">
        <title>Bacillus coagulans: a viable adjunct therapy 
for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial
</title>
        <description>Background:
Lactic acid-producing bacteria (LAB) probiotics demonstrate immunomodulating and anti-inflammatory effects and the ability to lessen the symptoms of arthritis in both animals and humans. This randomized, double-blind, placebo-controlled, parallel-design, clinical pilot trial was conducted to evaluate the effects of the LAB probiotic preparation, Bacillus coagulans GBI-30, 6086, on symptoms and measures of functional capacity in patients with rheumatoid arthritis (RA) in combination with pharmacological anti-arthritic medications.
Methods:
Forty-five adult men and women with symptoms of RA were randomly assigned to receive Bacillus coagulans GBI-30, 6086 or placebo once a day in a double-blind fashion for 60 days in addition to their standard anti-arthritic medications. Arthritis activity was evaluated by clinical examination, the American College of Rheumatology (ACR) criteria, the Stanford Health Assessment Questionnaire Disability Index (HAQ-DI), and laboratory tests for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
Results:
Subjects who received Bacillus coagulans GBI-30, 6086 experienced borderline statistically significant improvement in the Patient Pain Assessment score (P=.052) and statistically significant improvement in Pain Scale (P=.046) vs placebo. Compared with placebo, Bacillus coagulans GBI-30, 6086 treatment resulted in greater improvement in patient global assessment and self-assessed disability; reduction in CRP; as well as the ability to walk 2 miles, reach, and participate in daily activities. There were no treatment-related adverse events reported throughout this study.
Conclusions:
Results of this pilot study suggest that adjunctive treatment with Bacillus coagulans GBI-30, 6086 LAB probiotic appeared to be a safe and effective for patients suffering from RA. Because of the low study population size, larger trials are needed to verify these results.Trial registration: ACTRN12609000435280</description>
        <link>http://www.biomedcentral.com/1472-6882/10/1</link>
                <dc:creator>David Mandel</dc:creator>
                <dc:creator>Katy Eichas</dc:creator>
                <dc:creator>Judith Holmes</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2010, 10:1</dc:source>
        <dc:date>2010-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-10-1</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/53">
        <title>Attitude and use of herbal medicines among pregnant women in Nigeria</title>
        <description>Background:
The use of herbal medicines among pregnant women in Nigeria has not been widely studied.
Methods:
Opinion of 595 pregnant women in three geopolitical zones in Nigeria on the use of herbal medicines, safety on usage, knowledge of potential effects of herbal remedies on the fetus and potential benefits or harms that may be derived from combining herbal remedies with conventional therapies were obtained using a structured questionnaire between September 2007 and March 2008. Descriptive statistics and Fisher&apos;s exact tests were used at 95% confidence level to evaluate the data obtained. Level of significance was set at p &lt; 0.05.
Results:
More than two-third of respondents [67.5%] had used herbal medicines in crude forms or as pharmaceutical prepackaged dosage forms, with 74.3% preferring self-prepared formulations. Almost 30% who were using herbal medicine at the time of the study believed that the use of herbal medicines during pregnancy is safe. Respondents&apos; reasons for taking herbal medications were varied and included reasons such as herbs having better efficacy than conventional medicines [22.4%], herbs being natural, are safer to use during pregnancy than conventional medicines [21.1%], low efficacy of conventional medicines [19.7%], easier access to herbal medicines [11.2%], traditional and cultural belief in herbal medicines to cure many illnesses [12.5%], and comparatively low cost of herbal medicines [5.9%].Over half the respondents, 56.6% did not support combining herbal medicines with conventional drugs to forestall drug-herb interaction. About 33.4% respondents believed herbal medicines possess no adverse effects while 181 [30.4%] were of the opinion that adverse/side effects of some herbal medicines could be dangerous. Marital status, geopolitical zones, and educational qualification of respondents had statistically significant effects on respondents views on side effects of herbal medicines [p &lt; 0.05)] while only geopolitical zones and educational qualifications seemed to have influence on respondents&apos; opinion on the harmful effects of herbal medicines to the fetus [p &lt; 0.05].
Conclusion:
The study emphasized the wide spread use of herbal medicines by pregnant women in Nigeria highlighting an urgent need for health care practitioners and other health care givers to be aware of this practice and make efforts in obtaining information about herb use during ante-natal care. This will help forestall possible interaction between herbal and conventional medicines.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/53</link>
                <dc:creator>Titilayo Fakeye</dc:creator>
                <dc:creator>Rasaq Adisa</dc:creator>
                <dc:creator>Ismail Musa</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:53</dc:source>
        <dc:date>2009-12-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-53</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>53</prism:startingPage>
        <prism:publicationDate>2009-12-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/52">
        <title>Australian women&apos;s use of complementary and alternative medicines to enhance fertility: exploring the experiences of women and practitioners</title>
        <description>Background:
Studies exploring the use of complementary and alternative medicine (CAM) to enhance fertility are limited. While Australian trends indicate that women are using CAM during pregnancy, little is known about women&apos;s use of CAM for fertility enhancement. With the rising age of women at first birth, couples are increasingly seeking assisted reproductive technologies (ART) to achieve parenthood. It is likely that CAM use for fertility enhancement will also increase, however this is not known. This paper reports on an exploratory study of women&apos;s use of CAM for fertility enhancement.
Methods:
Three focus groups were conducted in Melbourne, Australia in 2007; two with women who used CAM to enhance their fertility and one with CAM practitioners. Participants were recruited from five metropolitan Melbourne CAM practices that specialise in women&apos;s health. Women were asked to discuss their views and experiences of both CAM and ART, and practitioners were asked about their perceptions of why women consult them for fertility enhancement. Groups were digitally recorded (audio) and transcribed verbatim. The data were analysed thematically.
Results:
Focus groups included eight CAM practitioners and seven women. Practitioners reported increasing numbers of women consulting them for fertility enhancement whilst also using ART. Women combined CAM with ART to maintain wellbeing and assist with fertility enhancement. Global themes emerging from the women&apos;s focus groups were: women being willing to &apos;try anything&apos; to achieve a pregnancy; women&apos;s negative experiences of ART and a reluctance to inform their medical specialist of their CAM use; and conversely, women&apos;s experiences with CAM being affirming and empowering.
Conclusions:
The women in our study used CAM to optimise their chances of achieving a pregnancy. Emerging themes suggest the positive relationships achieved with CAM practitioners are not always attained with orthodox medical providers. Women&apos;s views and experiences need to be considered in the provision of fertility services, and strategies developed to enhance communication between women, medical practitioners and CAM practitioners. Further research is needed to investigate the extent of CAM use for fertility enhancement in Australia, and to explore the efficacy and safety of CAM use to enhance fertility, in isolation or with ART.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/52</link>
                <dc:creator>Jo-Anne Rayner</dc:creator>
                <dc:creator>Helen McLachlan</dc:creator>
                <dc:creator>Della Forster</dc:creator>
                <dc:creator>Rhian Cramer</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:52</dc:source>
        <dc:date>2009-12-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-52</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>52</prism:startingPage>
        <prism:publicationDate>2009-12-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/51">
        <title>Aqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes</title>
        <description>Background:
Congaplex&#174; and Immuplex&#174; are dietary supplements that have been traditionally used to support immune system function. The purpose of these experiments was to determine whether Congaplex&#174; and Immuplex&#174; affect immune function using primary and immortalized T lymphocytes.
Methods:
Immortalized CEM and Jurkat T lymphocytes and primary peripheral mononuclear blood cells (PBMCs) were treated with the aqueous extracts from Congaplex&#174; and Immuplex&#174; to determine the effects of these products on cytokine production in activated T lymphocytes.
Results:
Congaplex&#174; enhanced phytohemagglutinin/phorbol 12-myristate 13-acetate (PHA/PMA) stimulation of both CEM and Jurkat cells as measured by the production of cytokines, while Immuplex&#174; suppressed PHA/PMA-induced production of cytokines, with the exception of interleukin (IL)-8 which was enhanced by Immuplex&#174;. In vitro treatment of PBMCs from 10 healthy donors with Congaplex&#174; or Immuplex&#174; decreased PHA-stimulated production of interferon (IFN)-&#947; but increased the production of IL-13.
Conclusions:
While the effects of Congaplex&#174; and Immuplex&#174; differed in these two models, these data demonstrate that the aqueous extracts from these two dietary supplements can affect the inflammatory response of T lymphocytes.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/51</link>
                <dc:creator>Paul Hanlon</dc:creator>
                <dc:creator>Melissa Robbins</dc:creator>
                <dc:creator>Chris Scholl</dc:creator>
                <dc:creator>David Barnes</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:51</dc:source>
        <dc:date>2009-12-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-51</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>51</prism:startingPage>
        <prism:publicationDate>2009-12-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/50">
        <title>Building resilience: A preliminary exploration of women&apos;s perceptions of the use of acupuncture as an adjunct to In Vitro Fertilisation
</title>
        <description>Background:
In Vitro Fertilisation (IVF) is now an accepted and effective treatment for infertility, however IVF is acknowledged as contributing to, rather than lessening, the overall psychosocial effects of infertility. Psychological and counselling interventions have previously been widely recommended in parallel with infertility treatments but whilst in many jurisdictions counselling is recommended or mandatory, it may not be widely used. Acupuncture is increasingly used as an adjunct to IVF, in this preliminary study we sought to investigate the experience of infertile women who had used acupuncture to improve their fertility.
Methods:
A sample of 20 women was drawn from a cohort of women who had attended for a minimum of four acupuncture sessions in the practices of two acupuncturists in South Australia. Eight women were interviewed using a semi-structured questionnaire. Six had sought acupuncture during IVF treatment and two had begun acupuncture to enhance their fertility and had later progressed to IVF. Descriptive content analysis was employed to analyse the data.
Results:
Four major categories of perceptions about acupuncture in relation to reproductive health were identified: (a) Awareness of, and perceived benefits of acupuncture; (b) perceptions of the body and the impact of acupuncture upon it; (c) perceptions of stress and the impact of acupuncture on resilience; and (d) perceptions of the intersection of medical treatment and acupuncture.
Conclusion:
This preliminary exploration, whilst confined to a small sample of women, confirms that acupuncture is indeed perceived by infertile women to have an impact to their health. All findings outlined here are reported cautiously because they are limited by the size of the sample. They suggest that further studies of acupuncture as an adjunct to IVF should systematically explore the issues of wellbeing, anxiety, personal and social resilience and women&apos;s identity in relation to sexuality and reproduction.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/50</link>
                <dc:creator>Sheryl de Lacey</dc:creator>
                <dc:creator>Caroline Smith</dc:creator>
                <dc:creator>Charlotte Paterson</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:50</dc:source>
        <dc:date>2009-12-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-50</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>50</prism:startingPage>
        <prism:publicationDate>2009-12-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
